Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer

NCT06478225 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Tumor Pancreas

Interventions

DRUG: BGT007H Cell Injection

Sponsor

RenJi Hospital